Testing effectiveness (Phase 2)Looking for participantsNCT06927739
What this trial is testing
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Who this might be right for
Acute Coronary SyndromesCoronary Arterial Disease (CAD)Inflammation+3 more
Abcentra 240